Document Preview Unavailable

Delayed inflammation decrease is associated with mortality in Tocilizumab-treated critically ill SARS-CoV-2 patients: A retrospective matched-cohort analysis

Urbina Tomas; Jean-Rémi, Lavillegrand; Garnier, Marc; Mekinian Arsene; Pacanowski Jerome; et al.  Innate Immunity Vol. 28, Iss. 1,  (Jan 2022): 3-10.

You might have access to this document